(Q39316744)

11 September 2017

title

Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs (English)

1 reference

11 September 2017

main subject

angiogenesis inhibitor

1 reference

Ronit Satchi-Fainaro

8

0 references

author name string

Liat Benayoun

1

1 reference

11 September 2017

Svetlana Gingis-Velitski

2

1 reference

11 September 2017

Tali Voloshin

3

1 reference

11 September 2017

Ehud Segal

4

1 reference

11 September 2017

Rotem Segev

5

1 reference

11 September 2017

Michal Munster

6

1 reference

11 September 2017

Rotem Bril

7

1 reference

11 September 2017

Stefan J Scherer

9

1 reference

11 September 2017

Yuval Shaked

10

1 reference

11 September 2017

publication date

1 September 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

30

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1831-1841

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

11 September 2017

cites work

1 reference

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

21 January 2018

1 reference

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

21 January 2018

1 reference

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

21 January 2018

1 reference

21 January 2018

On mammary stem cells

1 reference

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

21 January 2018

1 reference

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

21 January 2018

1 reference

G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist

21 January 2018

1 reference

A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line.

21 January 2018

1 reference

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells

21 January 2018

1 reference

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

Tumour stem cells and drug resistance

21 January 2018

1 reference

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

21 January 2018

1 reference

Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.

21 January 2018

1 reference

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

21 January 2018

1 reference

Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

21 January 2018

1 reference

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line

21 January 2018

1 reference

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties

21 January 2018

1 reference

Cancer stem cells in breast: current opinion and future challenges.

21 January 2018

1 reference

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

21 January 2018

1 reference

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.1170

1 reference

11 September 2017

1 reference